|

APL-4098 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Apollo Therapeutics Ltd1

Indications

  • Myelodysplastic Syndrome With Excess Blasts1
  • Acute Myeloid Leukemia, in Relapse1
  • Myelodysplastic Syndrome/Acute Myeloid Leukemia1
  • Acute Myeloid Leukemia Refractory1
  • Acute Myeloid Leukemia (AML)1

Other1 trial

A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.